Back to search

United States· US:70518-0132_4b190ae7-cfb1-c5df-e063-6294a90ac4e7

Benztropine Mesylate

A benzatropine product containing benztropine mesylate, registered in United States by REMEDYREPACK INC.. The same ATC class is registered in 5 of our 19 countries.

In shortageATC N04AC01US label

Checked against FDA National Drug Code directory (United States) on

Informational only — not a medical device.

SOURCE REGISTER · USFDA National Drug Code directory (Unite…normalisedBenztropine MesylateATCN04AC01REGISTER NO.US:70518-0132_4b190ae…PACKS LISTED2CHECKEDSeptember 12, 2026

Where it is registered

Benzatropine is registered in 5 of 19 countries.

Countries holding a registration under ATC N04AC01 (benzatropine), each read from that country’s own register.

  • This record: United States, from FDA National Drug Code directory (United States)
  • 3 of them publish a price we can compare per daily dose

Benzatropine · ATC N04AC01

5 / 19 countries

  • Canada
  • Finlandprice
  • Norwayprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FDA National Drug Code directory (United States)
Active substance
benztropine mesylate
Manufacturer
REMEDYREPACK INC.
Country
United States (US)
ATC code
N04AC01
ATC class
Benzatropine
Defined daily dose
2 mg, O
Reimbursed
Not published by this register
Source register
FDA National Drug Code directory (United States)
Last checked
September 12, 2026

Packs & prices · 2

  • ndc11
    7051801321
    30 TABLET in 1 BLISTER PACK (70518-0132-1)
  • ndc11
    7051801322
    100 POUCH in 1 BOX (70518-0132-2) / 1 TABLET in 1 POUCH (70518-0132-3)

Regulatory notes

UNII (FDA substance ID)
WMJ8TL7510
BENZTROPINE MESYLATE
RxCUI 18927
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Benztropine Mesylate Injection

Interactions

92 interactions on record for benzatropine.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Benzatropine · interactions on record

92 records

  • 3 severe
  • 88 moderate
  • 1 minor

Most severe, free to view

  • Potassium chlorideA12BA01severe
  • Potassium citrateA12BA02severe
  • Potassium chlorideB05XA01severe
  • DicycloverineA03AA07moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Benzatropine in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All benzatropine products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/fda6df7d-dfe3-4942-8211-fc9bb491ebd6
GET /v1/drugs/fda6df7d-dfe3-4942-8211-fc9bb491ebd6?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unii": {
    "unii": "WMJ8TL7510",
    "rxcui": "18927",
    "inchikey": "CPFJLLXFNPCTDW-BWSPSPBFSA-N",
    "display_name": "BENZTROPINE MESYLATE",
    "substance_type": "chemical",
    "ingredient_type": "INGREDIENT SUBSTANCE"
  },
  "route": "ORAL",
  "livertox": {
    "summary": null,
    "livertox_id": null,
    "hepatotoxicity_score": 5
  },
  "spl_meta": {
    "52bd605a-6a28-c2ec-e063-6294a90a8371": {
      "match": "brand_token",
      "title": "BENZTROPINE MESYLATE TABLET [COUPLER LLC]",
      "spl_version": "1",
      "published_date": "2026-05-28"
    }
  },
  "productid": "70518-0132_4b190ae7-cfb1-c5df-e063-6294a90ac4e7",
  "productndc": "70518-0132",
  "dosage_form": "TABLET",
  "dea_schedule": null,
  "product_type": "HUMAN PRESCRIPTION DRUG",
  "substance_name": "BENZTROPINE MESYLATE",
  "shortage_reason": "Benztropine Mesylate Injection",
  "shortage_status": "current",
  "proprietary_name": "Benztropine Mesylate",
  "active_ingred_unit": "mg/1",
  "application_number": "ANDA040742",
  "marketing_category": "ANDA",
  "nonproprietary_name": "benztropine mesylate",
  "start_marketing_date": "20170117",
  "active_numerator_strength": "1"
}

See everything about benzatropine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.